Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

PAROMOMYCIN SULFATE

PAROMOMYCIN SULFATE

Standard Dose
EQ 250MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Prescription
Summary

Approval overview PAROMOMYCIN SULFATE is listed in Drugs@FDA under application 065173 (ANDA).

Review priority: UNKNOWN Marketing status: Prescription Active ingredient PAROMOMYCIN SULFATE Form and strength CAPSULE;ORAL - EQ 250MG BASE Sponsor HERITAGE Submission history Latest submission status date: 2015-10-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview PAROMOMYCIN SULFATE is listed in Drugs@FDA under application 065173 (ANDA). Review priority: UNKNOWN Marketing status: Prescription Active ingredient PAROMOMYCIN SULFATE Form and strength CAPSULE;ORAL - EQ 250MG BASE Sponsor HERITAGE Submission history Latest submission status date: 2015-10-28 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: UNKNOWN

Interaction Notes

  • No interaction notes stored yet.